According to the latest report by IMARC Group, titled "Metagenomics Market Report by Product (Instruments and Software, Consumables), Technology (Sequencing, Bioinformatics), Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Agriculture), and Region 2025-2033," the global metagenomics market reached a value of USD 619.1 Million in 2024. Metagenomics refers to the research field that assists researchers in studying the characteristics of genetic substances that are acquired from environmental samples. It involves the usage of multiple molecular tools, such as bioinformatics and sequencing techniques, in order to determine the insights of microbial genomes and analyze the structure of the human microbiome. Additionally, it also assists laboratory professionals in identifying the relationship between antimicrobial resistance and pathogens. Apart from this, it also aids in evaluating the microbiomes that are associated with various chronic illnesses to develop personalized medicines and treatments.
Global Metagenomics Market Trends:
The global market is primarily driven by the rising prevalence of virus-induced infections. This is supported by the sudden outbreak of coronavirus disease (COVID-19) across the globe. Along with this, the increasing incidences of genetic disorders, especially among infants, and the rising geriatric population, which is more susceptible to medical ailments, are also contributing to the market growth. Moreover, continual technological advancements in the genomics industry, such as the widespread adoption of Artificial Intelligence (AI) technology that assists in genome mapping and annotation, are providing a boost to the market growth. Also, the introduction of next-generation sequencing (NGS) services is acting as a major growth-inducing factor. Furthermore, continuous improvements in the healthcare and pharmaceutical sectors are also projected to drive the market further. Some of the other factors contributing to the market growth include the rising demand for clinical diagnostics and drug discovery and increasing investments to conduct extensive research and development (R&D) activities. Looking forward, IMARC Group expects the market value to reach USD 1,454.1 Million by 2033, exhibiting a CAGR of 9.45% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Product, Technology, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal